ArticleTranslational lung cancer research2020

Hazard ratio of progression-free survival is an excellent predictor of overall survival in phase III randomized controlled trials evaluating the first-line chemotherapy for extensive-disease small-cell lung cancer.

Hao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.